IP Library Granted Patent US 12703879
Granted Patent B2
US 12703879 · App. 18/127,582 · Granted Aug 11, 2026

RNase H assisted in situ rolling circle amplification

Inventors: Yufeng Qian (Pleasanton, CA); Shankar Shastry (Pleasanton, CA)
Assignee: 10X GENOMICS, INC.
C12Q1/6844C12N9/22C12Q1/44C12Y301/26004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12703879
App. No.
18/127,582
Granted
Aug 11, 2026
Kind
B2
Abstract

The present disclosure relates in some aspects to methods for analyzing a target RNA in a biological sample, such as detection of a sequence of interest in an RNA. In some aspects, provided herein are methods of using an RNase such as RNase H to provide in situ RNA detection methods having high sensitivity, efficiency, and/or specificity.

Claims (34)

1 . A method for analyzing a biological sample, comprising:

(a) contacting the biological sample with a circular or circularizable probe, wherein the circular or circularizable probe comprises a hybridization region that hybridizes to a target RNA sequence in a target RNA in the biological sample to form a duplex,

(b) contacting the biological sample comprising the target RNA hybridized to the circular or circularizable probe with a primer oligonucleotide, a ribonuclease H (RNase H), and a polymerase, wherein the primer oligonucleotide comprises a sequence complementary to a sequence in the circular or circularizable probe, and the RNase H cleaves the target RNA in the duplex at one or more sites in the target RNA sequence;

(c) performing rolling circle amplification (RCA) using the circular probe or a circularized probe formed by circularizing the circularizable probe as an RCA template; and

(d) detecting one or more products of the RCA, thereby detecting the target RNA or a sequence thereof in the biological sample.

2 . The method of claim 1 , wherein the method comprises ligating the circularizable probe to form the circularized probe and performing the RCA using the circularized probe as the RCA template.

3 . The method of claim 2 , wherein the ligating is performed using the target RNA sequence as a ligation template.

4 . The method of claim 2 , wherein the ligating is performed prior to contacting the biological sample with the RNase H.

5 . The method of claim 1 , wherein the biological sample is contacted with the primer oligonucleotide, the RNase H, and the polymerase simultaneously.

6 . The method of claim 1 , wherein the biological sample is contacted with the RNase H prior to contacting the biological sample with the primer oligonucleotide and the polymerase.

7 . The method of claim 1 , wherein the biological sample is contacted with the RNase H prior to contacting the biological sample with the polymerase.

8 . The method of claim 1 , wherein the polymerase is a Phi29 DNA polymerase or a Bst DNA polymerase.

9 . The method of claim 1 , wherein the RNase is an RNase H1 or an RNase H2.

10 . The method of claim 1 , wherein (b) comprises: contacting the biological sample with the RNase H

in a first buffer that is free or substantially free of a cofactor for the RNase H,

followed by incubating the biological sample with the RNase H and the cofactor.

11 . The method of claim 10 , further comprising:

incubating the biological sample with the RNase H in the first buffer, thereby allowing the RNase H to bind the target RNA, the circular or circularizable probe, or the duplex;

removing excess RNase H from the biological sample; and

incubating the biological sample in a second buffer which comprises the RNase H and the cofactor, thereby allowing the RNase H to cleave at the one or more sites in the target RNA sequence.

12 . The method of claim 1 , wherein the one or more products of the RCA comprise an RCA product generated by using the primer oligonucleotide as a primer.

13 . The method of claim 1 , wherein the biological sample is contacted with the RNase H at a concentration of between about 1×10 −3 U/μL and about 2×10 −2 U/μL.

14 . The method of claim 1 , wherein the detecting comprises contacting the one or more RCA products with a plurality of detectable probes in sequential cycles.

15 . A method for analyzing a biological sample, comprising:

(a) contacting the biological sample with a circularizable probe comprising a hybridization region that hybridizes to a target RNA sequence in a target RNA in the biological sample to form a duplex,

(b) ligating the circularizable probe to form a circularized probe;

(c) contacting the biological sample comprising the target RNA hybridized to the circularized probe with (i) a primer oligonucleotide that comprises a sequence complementary to a sequence in the circularized probe, (ii) a ribonuclease H (RNase H), and (iii) a Phi29 DNA polymerase,

wherein the contacting comprises contacting the biological sample with the RNase H in a first buffer that is free or substantially free of a cofactor for the RNase H, followed by incubating the biological sample in a second buffer comprising the RNase H and the cofactor;

(d) performing rolling circle amplification (RCA) using the circularized probe as an RCA template; and

(e) detecting one or more products of the RCA, thereby detecting the target RNA or a sequence thereof in the biological sample.

16 . The method of claim 10 , wherein the cofactor for the RNase H is Mg 2+ .

17 . The method of claim 1 , wherein the biological sample is a cell or tissue sample.

18 . The method of claim 17 , wherein the one or more products of the RCA are detected at location(s) in the biological sample immobilized on a solid support.

19 . The method of claim 1 , wherein the detecting comprises contacting the one or more RCA products with a plurality of intermediate probes each comprising: (i) a sequence that hybridizes to the one or more RCA products and (ii) a sequence that hybridizes to one or more detectable probes.